Bank Julius Baer & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174M | Sell |
391,376
-6,655
| -2% | -$2.96M | 0.52% | 55 |
|
|
2025
Q1 | $194M | Buy |
398,031
+29,064
| +8% | +$14.1M | 0.63% | 44 |
|
|
2024
Q4 | $159M | Buy |
368,967
+33,322
| +10% | +$14.4M | 0.49% | 49 |
|
|
2024
Q3 | $178M | Buy |
335,645
+322,142
| +2,386% | +$170M | 0.6% | 44 |
|
|
2024
Q2 | $5.88M | Sell |
13,503
-272,605
| -95% | -$119M | 0.02% | 177 |
|
|
2024
Q1 | $119M | Buy |
286,108
+10,735
| +4% | +$4.48M | 0.46% | 59 |
|
|
2023
Q4 | $112M | Buy |
275,373
+89,743
| +48% | +$36.5M | 0.47% | 60 |
|
|
2023
Q3 | $64.6M | Buy |
185,630
+13,969
| +8% | +$4.86M | 0.38% | 69 |
|
|
2023
Q2 | $60.4M | Buy |
171,661
+204
| +0.1% | +$71.8K | 0.36% | 68 |
|
|
2023
Q1 | $54M | Buy |
171,457
+1,087
| +0.6% | +$342K | 0.34% | 71 |
|
|
2022
Q4 | $49.2M | Buy |
170,370
+162,295
| +2,010% | +$46.9M | 0.34% | 70 |
|
|
2022
Q3 | $2.34M | Buy |
8,075
+3,767
| +87% | +$1.09M | 0.02% | 191 |
|
|
2022
Q2 | $1.21M | Buy |
4,308
+1,189
| +38% | +$335K | 0.01% | 252 |
|
|
2022
Q1 | $814K | Buy |
3,119
+2,659
| +578% | +$694K | ﹤0.01% | 303 |
|
|
2021
Q4 | $101K | Sell |
460
-4,515
| -91% | -$991K | ﹤0.01% | 604 |
|
|
2021
Q3 | $902K | Buy |
4,975
+2,093
| +73% | +$379K | 0.01% | 345 |
|
|
2021
Q2 | $581K | Buy |
2,882
+703
| +32% | +$142K | ﹤0.01% | 429 |
|
|
2021
Q1 | $468K | Sell |
2,179
-14,069
| -87% | -$3.02M | ﹤0.01% | 459 |
|
|
2020
Q4 | $3.84M | Buy |
16,248
+7,852
| +94% | +$1.86M | 0.03% | 210 |
|
|
2020
Q3 | $2.23M | Buy |
8,396
+2,220
| +36% | +$591K | 0.02% | 214 |
|
|
2020
Q2 | $1.79M | Sell |
6,176
-851
| -12% | -$247K | 0.02% | 206 |
|
|
2020
Q1 | $1.67M | Buy |
+7,027
| New | +$1.67M | 0.04% | 170 |
|